MicroRNAs, wild-type and mutant p53 More questions than answers

被引:44
|
作者
Jones, Matthew Fletcher [1 ]
Lal, Ashish [1 ]
机构
[1] NCI, Genet Branch, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
miRNA; p53; mutant p53; wild-type p53; cancer; miRNA dysregulation; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-SUPPRESSOR P53; DOWN-REGULATION; MIR-200; FAMILY; E-CADHERIN; MIR-34A CONTRIBUTES; NEGATIVE REGULATION; TARGET RECOGNITION; CELL-PROLIFERATION; MIR-17-92; CLUSTER;
D O I
10.4161/rna.20146
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tumor suppressor p53 is a sequence-specific transcription factor that activates the expression of genes involved in apoptosis, cell cycle arrest and senescence. p53 can also inhibit gene expression and this effect is partly mediated by inducing several microRNAs (miRNAs). MiRNAs have emerged as a new class of regulators of the expression and function of eukaryotic genomes. Tumor suppressive or oncogenic functions have been attributed to some miRNAs. Recent studies have shown that p53 can alter the transcription of several miRNAs, and in some cases, it can also influence miRNA maturation. Conversely, miRNAs can also modulate the abundance and activity of p53 by direct or indirect mechanisms. Moreover, mutant p53 can actively repress the expression of some miRNAs that are activated by wild-type p53. In this review, we discuss recent evidences of this crosstalk between miRNAs and the p53 network and also highlight its implications in cancer.
引用
收藏
页码:781 / 791
页数:11
相关论文
共 50 条
  • [1] COTRANSLATION OF ACTIVATED MUTANT P53 WITH WILD-TYPE DRIVES THE WILD-TYPE P53 PROTEIN INTO THE MUTANT CONFORMATION
    MILNER, J
    MEDCALF, EA
    CELL, 1991, 65 (05) : 765 - 774
  • [2] Activities of wild-type and mutant p53
    Vousden, Karen H.
    CANCER RESEARCH, 2013, 73
  • [3] p53 alterations in human cancer: more questions than answers
    Soussi, T.
    ONCOGENE, 2007, 26 (15) : 2145 - 2156
  • [4] p53 alterations in human cancer: more questions than answers
    T Soussi
    Oncogene, 2007, 26 : 2145 - 2156
  • [5] TUMOR SUPPRESSOR P53 - ANALYSIS OF WILD-TYPE AND MUTANT P53 COMPLEXES
    MILNER, J
    MEDCALF, EA
    COOK, AC
    MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (01) : 12 - 19
  • [6] Modulation of MDR/MRP by wild-type and mutant p53
    Bähr, O
    Wick, W
    Weller, M
    JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (05): : 643 - 645
  • [7] Mutant p53: Gain-of-function oncoproteins and wild-type p53 inactivators
    Roemer, K
    BIOLOGICAL CHEMISTRY, 1999, 380 (7-8) : 879 - 887
  • [8] REGULATION OF THE STRUCTURE AND FUNCTION OF WILD-TYPE AND MUTANT FORMS OF P53
    BARGONETTI, J
    CHEN, XB
    FARMER, G
    FRIEDLANDER, P
    JAYARAMAN, L
    MANFREDI, J
    MILLER, S
    WANG, Y
    PRIVES, C
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 162 - 162
  • [9] 2 CELLULAR PROTEINS THAT BIND TO WILD-TYPE BUT NOT MUTANT P53
    IWABUCHI, K
    BARTEL, PL
    LI, B
    MARRACCINO, R
    FIELDS, S
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (13) : 6098 - 6102
  • [10] MUTANT p53 ALLELES CAN BE RESTORED TO THE WILD-TYPE CONFORMATION
    不详
    CANCER DISCOVERY, 2012, 2 (07) : 581 - 581